Siemens Healthineers and Biogen plan to jointly develop magnetic resonance imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Hear more about the project from Elizabeth Fisher, Senior Director, Research Technology.